Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway.

Sun H, Guo X, Wang Z, Wang P, Zhang Z, Dong J, Zhuang R, Zhou Y, Ma G, Cai W.

Oxid Med Cell Longev. 2019 Feb 10;2019:3142732. doi: 10.1155/2019/3142732. eCollection 2019.

2.

Study of nuclear factor-2 erythroid related factor-2 activator, berberine, in paclitaxel induced peripheral neuropathy pain model in rats.

Singh J, Saha L, Singh N, Kumari P, Bhatia A, Chakrabarti A.

J Pharm Pharmacol. 2019 May;71(5):797-805. doi: 10.1111/jphp.13047. Epub 2018 Dec 10.

PMID:
30536411
3.

Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer.

Kinoshita J, Fushida S, Tsukada T, Oyama K, Watanabe T, Shoji M, Okamoto K, Nakanuma S, Sakai S, Makino I, Furukawa H, Hayashi H, Nakamura K, Inokuchi M, Nakagawara H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Fujimura T, Masakazu Y, Hirakawa K, Ohta T.

Oncol Rep. 2014 Jul;32(1):89-96. doi: 10.3892/or.2014.3210. Epub 2014 May 23.

PMID:
24859429
4.

Effects of ginsenoside Rb1 on oxidative stress injury in rat spinal cords by regulating the eNOS/Nrf2/HO-1 signaling pathway.

Liu X, Gu X, Yu M, Zi Y, Yu H, Wang Y, Xie Y, Xiang L.

Exp Ther Med. 2018 Aug;16(2):1079-1086. doi: 10.3892/etm.2018.6286. Epub 2018 Jun 12.

5.

Protective effects of nuclear factor erythroid 2-related factor 2 on whole body heat stress-induced oxidative damage in the mouse testis.

Li Y, Huang Y, Piao Y, Nagaoka K, Watanabe G, Taya K, Li C.

Reprod Biol Endocrinol. 2013 Mar 21;11:23. doi: 10.1186/1477-7827-11-23.

6.

Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway.

Al-Massri KF, Ahmed LA, El-Abhar HS.

Behav Brain Res. 2019 Mar 15;360:303-311. doi: 10.1016/j.bbr.2018.12.013. Epub 2018 Dec 10.

PMID:
30543902
7.

Lipoic Acid Prevents High-Fat Diet-Induced Hepatic Steatosis in Goto Kakizaki Rats by Reducing Oxidative Stress Through Nrf2 Activation.

Sena CM, Cipriano MA, Botelho MF, Sei├ža RM.

Int J Mol Sci. 2018 Sep 11;19(9). pii: E2706. doi: 10.3390/ijms19092706.

8.

Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.

Rajeshkumar NV, Yabuuchi S, Pai SG, Tong Z, Hou S, Bateman S, Pierce DW, Heise C, Von Hoff DD, Maitra A, Hidalgo M.

Br J Cancer. 2016 Aug 9;115(4):442-53. doi: 10.1038/bjc.2016.215. Epub 2016 Jul 21.

9.

Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.

Takashima T, Kawajiri H, Nishimori T, Tei S, Nishimura S, Yamagata S, Tokunaga S, Mizuyama Y, Sunami T, Tezuka K, Ikeda K, Ogawa Y, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Kudoh S, Takada M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Jan;38(1):379-383.

PMID:
29277798
10.

Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Ganugula R, Deng M, Arora M, Pan HL, Kumar MNVR.

ACS Chem Neurosci. 2019 Mar 20;10(3):1801-1812. doi: 10.1021/acschemneuro.8b00703. Epub 2019 Jan 17.

PMID:
30609902
11.

Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.

Tsuyuki S, Senda N, Kanng Y, Yamaguchi A, Yoshibayashi H, Kikawa Y, Katakami N, Kato H, Hashimoto T, Okuno T, Yamauchi A, Inamoto T.

Breast Cancer Res Treat. 2016 Nov;160(1):61-67. Epub 2016 Sep 12.

PMID:
27620884
12.

[A Case of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy without Exacerbation].

Uchiyama M, Goto T, Ueno M, Kakimoto H, Mashima K, Ikari Y, Takamatsu Y, Ogata K, Kamimura H.

Gan To Kagaku Ryoho. 2017 Jun;44(6):517-519. Japanese.

PMID:
28698445
13.

Management of peripheral neuropathy induced by nab-paclitaxel treatment for breast cancer.

Ohno T, Mine T, Yoshioka H, Kosaka M, Matsuda S, De Kerckhove M, De Kerckhove C, Irie J, Inoue K, Haraguchi M, Kitajima M, Shinichiro I, Tokai H, Tanaka T, Izumida R.

Anticancer Res. 2014 Aug;34(8):4213-6.

PMID:
25075049
14.

Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer.

You MS, Ryu JK, Choi YH, Choi JH, Huh G, Paik WH, Lee SH, Kim YT.

Gut Liver. 2018 Nov 15;12(6):728-735. doi: 10.5009/gnl18220.

15.

Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.

Borsoi C, Leonard F, Lee Y, Zaid M, Elganainy D, Alexander JF, Kai M, Liu YT, Kang Y, Liu X, Koay EJ, Ferrari M, Godin B, Yokoi K.

Cancer Lett. 2017 Sep 10;403:296-304. doi: 10.1016/j.canlet.2017.06.026. Epub 2017 Jul 4.

16.

Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.

Murakami T, Murata T, Kawaguchi K, Kiyuna T, Igarashi K, Hwang HK, Hiroshima Y, Hozumi C, Komatsu S, Kikuchi T, Lwin TM, Delong JC, Miyake K, Zhang Y, Tanaka K, Bouvet M, Endo I, Hoffman RM.

Anticancer Res. 2017 Jan;37(1):61-65.

17.

Electroacupuncture enhances antioxidative signal pathway and attenuates neuropathic pain induced by chemotherapeutic paclitaxel.

Zhao X, Liu L, Wang Y, Wang G, Zhao Y, Zhang Y.

Physiol Res. 2019 Mar 22. [Epub ahead of print]

18.

Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy.

Duggett NA, Griffiths LA, McKenna OE, de Santis V, Yongsanguanchai N, Mokori EB, Flatters SJ.

Neuroscience. 2016 Oct 1;333:13-26. doi: 10.1016/j.neuroscience.2016.06.050. Epub 2016 Jul 5.

19.

Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.

Miyake K, Murata T, Murakami T, Zhao M, Kiyuna T, Kawaguchi K, Igarashi K, Miyake M, Lwin TM, Hozumi C, Komatsu S, Kikuchi T, Bouvet M, Shimoya K, Singh SR, Endo I, Hoffman RM.

Arch Gynecol Obstet. 2019 Apr 5. doi: 10.1007/s00404-019-05147-3. [Epub ahead of print]

PMID:
30953192
20.

Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer.

Hirsh V, Okamoto I, Hon JK, Page RD, Orsini J, Sakai H, Zhang H, Renschler MF, Socinski MA.

J Thorac Oncol. 2014 Jan;9(1):83-90. doi: 10.1097/JTO.0000000000000011.

Supplemental Content

Support Center